Clin Nephrol. 2022 Mar;97(3):141-148. doi: 10.5414/CN110532.
During the COVID-19 pandemic, there has been a reduction in emergency department visits and hospital admissions. We hypothesized that hemodialysis patients were decreasing their hospital visits and increasing their dialysis adherence during the COVID-19 pandemic.
This is a retrospective analysis of hemodialysis patients treated in the seven American Renal Associates (ARA) dialysis centers in the Dallas-Fort Worth metropolitan area. We conducted a "before-and-after" study using existing clinical data to examine patient adherence with hemodialysis between January 1 and March 14, 2020 (pre-COVID) and March 15 to May 18, 2020 (COVID) time periods. Data points included missed treatments, shortened treatments, post-dialysis weight, and hospital visits. Finally, we conducted an anonymous survey in which patients reported their hemodialysis adherence.
Data analysis was performed on 556 patients. Significantly fewer patients missed a single treatment in the COVID vs. pre-COVID time periods (44.1 vs. 58.6%; p < 0.001). Significantly fewer patients finished their treatment with a post-dialysis weight more than 1 kg above their estimated dry weight in the COVID vs. pre-COVID time periods (31.7 vs. 38.9%, p = 0.01). Finally, there was a reduction in total hospital visits during the COVID vs. pre-COVID periods (12.6 vs. 19.4%; p = 0.002). The anonymous survey showed patients reporting increased adherence with hemodialysis and restriction of salt and water intake.
The COVID time period was associated with increased adherence with hemodialysis and decreased hospital visits, and patients were conscious of these changes.
在 COVID-19 大流行期间，急诊科就诊和住院人数有所减少。我们假设在 COVID-19 大流行期间，血液透析患者减少了去医院的次数，并增加了透析的依从性。
这是一项对在达拉斯-沃斯堡大都市区的 7 个美国肾脏协会（ARA）透析中心接受治疗的血液透析患者进行的回顾性分析。我们使用现有的临床数据进行了一项“前后”研究，以检查 2020 年 1 月 1 日至 3 月 14 日（COVID-19 之前）和 2020 年 3 月 15 日至 5 月 18 日（COVID-19 期间）患者对血液透析的依从性。数据点包括错过的治疗、缩短的治疗、透析后的体重和住院次数。最后，我们进行了一项匿名调查，其中患者报告了他们的血液透析依从性。
对 556 名患者进行了数据分析。在 COVID 期间，错过单次治疗的患者明显少于 COVID-19 之前（44.1% vs. 58.6%；p < 0.001）。在 COVID 期间，与 COVID-19 之前相比，完成治疗后透析后体重超过估计干体重 1 公斤以上的患者明显减少（31.7% vs. 38.9%，p = 0.01）。最后，COVID 期间的总住院次数减少（12.6% vs. 19.4%；p = 0.002）。匿名调查显示，患者报告血液透析依从性提高，限制盐和水的摄入。
COVID 期间与血液透析依从性提高和住院次数减少相关，并且患者意识到了这些变化。
